Chimeric Therapeutics Competitors and Similar CompaniesClear all
Chimeric Therapeutics's competitors and similar companies include Cellares, Polyplus-transfection and Codiak Biosciences.
 Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. | |||
Founding Date | Founding Date 2020 | Founding Date 2019 | Founding Date 2002 | Founding Date 2015 |
Type | Type Public | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Carlton, AU HQ | Locations South San Francisco, US HQ | Locations Illkirch-Graffenstaden, FR HQ New York, US | Locations Cambridge, US HQ |
Employees | Employees N/A | Employees 2613% increase | Employees 1133% increase | Employees 992% decrease |
Valuation ($) | Valuation ($) 8.6 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.8 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $22.9m (FY, 2021) |
Net income | Net income ($10.4m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($37.2m) (FY, 2021) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 3.2m | Total funding raised $ 168.5m |
For sources of this data, please see the company profile
View Company Profiles
Cellares
HQ
South San Francisco, US
Employees
261↑ 3% increase
Cellares is a provider of cell therapy manufacturing services.
View companyPolyplus-transfection
HQ
Illkirch-Graffenstaden, FR
Employees
113↑ 3% increase
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View companyCodiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View company